Trade Summary

4 days ago, BOUDREAUX GAIL, serving as President and CEO at Elevance Health, Inc. (ELV), purchased 2,725 shares at $367.79 per share, for a total transaction value of $1,002,230.05. Following this transaction, BOUDREAUX GAIL now holds 171,976 shares of ELV.

This purchase represents a 1.61% increase in BOUDREAUX GAIL's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, July 17, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 17, 2026 at 1:50 PM ET, meaning the disclosure happened on the same day as the trade.

Elevance Health, Inc. operates in the HEALTHCARE sector, specifically within the HEALTHCARE PLANS industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.